# Access Protocol. Infusion of CD34+ Enriched, T Cell Depleted Hematopoietic Stem Cell Grafts.

> **NCT02158767** · — · NO_LONGER_AVAILABLE · sponsor: **Leland Metheny**

## Conditions studied

- Hematopoietic/Lymphoid Cancer

## Interventions

- **BIOLOGICAL:** Allogenic T cell-depleted hematopoietic stem cell transplantation

## Key facts

- **NCT ID:** NCT02158767
- **Lead sponsor:** Leland Metheny
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** NO_LONGER_AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2025-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02158767

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02158767, "Access Protocol. Infusion of CD34+ Enriched, T Cell Depleted Hematopoietic Stem Cell Grafts.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02158767. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*